Key facts
- It has raised $19.1M across 1 recorded rounds; the latest was Seed Round ($3.2M) in Aug 2019.
- Notable investors include Alumni Ventures, Matter (Consulting Services (B2B)), New York Angels, WARF Ventures, CancerX (USA) — 15 tracked in total.
- AIQ Solutions has filed 1 Form D with the SEC, most recently Aug 2019 ($3.2M sold to 11 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for AIQ Solutions
Funding rounds
1 roundsAbout AIQ Solutions
Developer of a medical device designed for the evaluation of treatment response in patients with cancer. The company's device localizes and identifies all the individual lesions based on molecular imaging, quantifies the disease burden associated with it, and calculates a comprehensive set of treatment response metrics consisting of different SUV measures, enabling healthcare professionals to effectively manage patients, improve patient outcomes, and reduce healthcare system costs.
- Sector
- Healthcare
- HQ
- Madison, WI, United States
- Founded
- 2015
- Employees
- 20
- Website
- aiq-solutions.com/
- Ownership
- Privately Held (backing)
AIQ Solutions doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in AIQ Solutions shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on AIQ Solutions in its N-PORT filings yet. We sweep new filings monthly.